Skip to content

Role of Individualized Homoeopathic Medicine in the Treatment of Varicose Vein

ASSESSING THE MIASM AND EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN THE MANAGEMENT OF VARICOSE VEIN - A QUASI EXPERIMENTAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102325
Enrollment
55
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I838- Varicose veins of lower extremities with other complications

Interventions

Intervention1: Individualized Homoeopathic remedy: Remedy will be prescribed after complete case taking and making totality to symptoms and repertorization and dosage will be selected upon the suscept

Sponsors

Government Homoeopathic Medical College and hospital bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are willing to take part in the study and sign the written informed consent form. Subjects of age group from 20-60 years. Newly Diagnosed case of varicose veins of lower limb belonging to C2 categories of CEAP classification.

Exclusion criteria

Exclusion criteria: Subjects with complications of Varicose vein thrombophlebitis , deep vein thrombosis , varicose ulcer. Subjects taking medicines from other systems of medicine for the same complaints. Pregnant women and lactating mothers. Subjects having under lying disease like uncontrolled diabetes, Cardiovascular disorders,Coagulation disorders.

Design outcomes

Primary

MeasureTime frame
When the revised venous clinical severity score represents zero and no signs and symptoms present.Timepoint: For first 3 months for every 15 days and for next 3 months once in a month follow up will be done.

Secondary

MeasureTime frame
when the venous clinical severity score represents reduction in score from base line 50%, with presence of few signs and symptoms.Timepoint: For first 3 months for every 15 days and for next 3 months once in a month follow up will be done.

Countries

India

Contacts

Public ContactDR AISHWARYA

Indian

drvijayalaxmi.angadi@gmail.com9448989575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026